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Abstract

With advances in acute medical care, longevity has increased in persons with SCI;
however, morbidity due to cardiovascular disease (CVD) occurs at an earlier age compared to
the general population. Arterial stiffness (AS) is recognized as an independent risk factor for
CVD and, specifically, pulse wave velocity (PWV) has been proven to be a valid tool to predict
and track structural arterial changes that reflect arteriosclerosis. Evidence has shown that persons
with SCI have increased AS compared to uninjured able-bodied controls; however, possible
contributors to this increase are not yet fully understood. After a SCI, sympathetic control in the
regions below the lesion level are severely disrupted; however, parasympathetic function is
preserved. Due to the dissociation between the two systems, those with lesions above T6
experience low resting blood pressure (BP) and further decreases in BP when changing postures
(orthostatic hypotension (OH)). As a consequence, individuals with high-level injuries have a
heightened reliance on the renin-angiotensin-aldosterone system (RAAS) to maintain and
stabilize BP. A mechanism for increased AS in the uninjured population is over activation of the
RAAS. In this study, individuals with high-level SCI (injured above T1) and low-level SCI
(injured between T6-T12) had increased AS compared to age-matched controls. The change in
renin from supine rest to 60-degree head-up tilt (HUT) was a significant predictor to the change
in systolic BP; however, the group predictor was not significant. Additionally, group and change
in renin were significant predictors to AS. The data indicate that individuals with high-level
injuries rely heavily on RAAS to maintain and normalize BP during OH, which is correlated to
increased AS. A better way to treat asymptomatic OH in the SCI population is needed to
decrease CVD.
iii

Keywords: spinal cord injury, orthostatic hypotension, renin-angiotensin-aldosterone
system, cardiovascular disease, arterial stiffness

iv

TABLE OF CONTENTS
ABSTRACT……………………………………………………………………………………...iii
CHAPTER I INTRODUCTION……………………………………………………………..……1
CHAPTER II LITERATURE REVIEW………………………………………………………….5
Summation and Relevance……………………………………………………………….19
Theoretical Framework…………………………………………………………………..20
Gaps……………………………………………………………………………………...21
Scientific Relevance……………………………………………………………………...22
Summary ………………………………………………………………………………...23
CHAPTER III METHODS………………………………………………………………………24
Participants……………………………………………………………………………….24
Procedure……………………………………………………………………………...…25
Tilt Table…………………………………………………………………………………26
Pulse Wave Velocity……………………………………………………………………..26
Hormonal Assessments…………………………………………………………………..27
Data Analysis ……………………………………………………………………………27
CHAPTER IV RESULTS & DISCUSSION…………………………………………………….28
Participant Characteristics……………………………………………………………….29
Hemodynamics…………………………………………………………………………..29
Heart Rate………………………………………………………………………………..29
Systolic Blood Pressure………………………………………………………………….29
Diastolic Blood Pressure…………………………………………………………………29
Plasma Renin Responses…………………………………………………………………29
Arterial Stiffness……………………………………………………………...………….30
Change in Hormonal Response……………………………………………………….….30
Orthostatic Blood Pressure and Renin……………………………………………...……30
Arterial Stiffness and Renin……………………………………………...………………31
Discussion………………………………………………………………………………..31
Arterial Stiffness by Group………………………………………………………………32
Orthostatic Blood Pressure and Renin Levels…………………………………………...34
Plasma Renin and Arterial Stiffness……………………………………………………..34
CHAPTER V SUMMARY AND CONCLUSIONS…………………………………………….36
Conclusions……………………………………………………………………………....36
Limitations……………………………………………………………………………….36
Future Research………………………………………………………………………….37
v

REFERENCES…………………………………………………………………………………..38
APPENDIXES ………………………………………………………………………………..…55
Seton Hall University IRB Approval…………………………………………………….55
Veterans Affair Medical Center IRB Approval……………………………………….....56
Kessler Foundation IRB Approval……………………………………………………….57

vi

Chapter I

INTRODUCTION

Approximately 17,000 new spinal cord injuries (SCI) occur each year in the United States
(National Spinal Cord Injury Statistical Center). The spinal cord is a critical component to send
sensory information to the brain and for regulation of motor and autonomic functions (Kirshblum
& Campagnolo, 2011, p. 6). The loss of the supraspinal control leads to reduced control of
overall sympathetic activity below the level of lesion (LOI) and unopposed parasympathetic
outflow through the intact vagal nerve. Disruption of the autonomic nervous system (ANS) leads
to altered cardiovascular function including heart rate (HR), blood pressure (BP) and vasomotor
tone (Kirshblum & Campagnolo, 2011, p. 136). Due to segmental differences in sympathetic
innervation, cardiovascular dysfunction is directly related to the specific level and severity of the
SCI, including resting hypotension (low BP) and large fluctuations in BP (Kirshblum &
Campagnolo, 2011, p. 136; Krassioukov, Warburton, Teasell, Eng, & Team, 2009; Lee, Phillips,
& Krassioukov, 2017). Early recognition and management of cardiovascular dysfunction is
important in the SCI population.
Cardiovascular disease (CVD) has emerged as the leading cause of mortality in individuals
with SCI (Cragg, Noonan, Krassioukov, & Borisoff, 2013; Hagen, Lie, Rekand, Gilhus, &
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Gronning, 2010). In fact, it has been speculated that premature cardiovascular aging in persons
with SCI may be due to chronic inflammation (Wang et al., 2007), sedentary lifestyle (Stoner,
Credeur, Dolbow, & Gater, 2015), and dysfunction in cardiovascular autonomic control (Myers,
Lee, & Kiratli, 2007; West, Mills, & Krassioukov, 2012). Matos–Souza and colleagues (2009)
demonstrated that individuals with SCI had higher common carotid artery (CCA) intima-media
thickness (measure of vascular stiffness) than able-bodied controls even after controlling for
traditional cardiovascular risk factors (Matos-Souza et al., 2009). Thus, other non-traditional risk
factors may play a role in increased atherosclerosis (hardening of arterial walls).
Individuals with injuries above T6 are more prone to experience orthostatic hypotension
(OH) which is a decrease in BP within 3-minutes of moving from supine to the upright position,
with or without symptoms (Neurology, 1996). Evidence has suggested that there is an
association between markedly reduced plasma norepinephrine (NE) and orthostatic hypotension
(OH) (Claydon, Steeves, & Krassioukov, 2006; Wecht & Bauman, 2018; Wecht et al., 2008).
Decreased NE reflects impaired sympathetically mediated vasoconstriction and inability to
stimulate the adrenal medulla (Claydon et al., 2006). However, these individuals have reduced
symptoms associated with pre-syncope which is believed to be due to increased dependency on
the renin-angiotensin-aldosterone system (RAAS), which has been shown to occur independently
of the SNS p. 142 (Kirshblum & Campagnolo, 2011; Wecht & Bauman, 2018). Individuals with
a diminished plasma NE response to OH may demonstrate increased reliance on the RAAS for
BP maintenance.
A possible link between increased RAAS and arterial stiffness (AS) may explain the
increased incidence of CVD in the SCI population (Katzelnick et al., 2017; Wecht & Bauman,
2018). In the general population, inappropriate chronic activation of RAAS activates signal
2

transduction pathways that promote cell growth, inflammation and fibrosis (Duprez, 2006).
Thus, individuals with high cord lesions may be more susceptible to increased AS; however, the
association between RAAS and AS in the SCI population has not been established. Increased AS
has been reported in high-level SCI (C3-T5) compared to low-level SCI (T7-T12) (Katzelnick
2017); while other prior work has documented increased AS in low-level SCI (T1-T12)
compared to high-level SCI (C2-C8) (Miyatani et al., 2014). Further investigation is needed to
ascertain the relationship between lesion level and AS.
Non-invasive testing modalities have been developed to more easily and accurately screen
AS and track atherosclerosis (Stoner et al., 2015). Specifically, pulse wave velocity (PWV)
measured at the carotid and femoral arteries is considered the gold standard measurement of AS
(Stoner et al., 2015; Van Bortel et al., 2011) because of its high reliability (Currie, Hubli, &
Krassioukov, 2014; Miyatani et al., 2012) and validity to track CVD (Van Bortel et al., 2011;
Vlachopoulos et al., 2010). PWV is calculated by measuring the time taken for the arterial
waveform to pass between two points (carotid and femoral) of a measured distance apart (Stoner
et al., 2015; Van Bortel et al., 2011).
The primary purpose of this research study will be to investigate the influence of orthostatic
change of BP and NE on the RAAS responses to orthostasis. Our first hypothesis is there will be
a linear relationship between the change in orthostatic BP and change in plasma NE
concentration from supine rest to 60º HUT. Second hypothesis is plasma renin activity will be
inversely related to plasma NE concentrations during HUT in persons with SCI. Additionally,
our secondary aim will be to determine if increased reliance on the RAAS for orthostatic BP
regulation contributes to differences in supine AS in individuals with SCI. Our hypotheses are
the change of renin from supine rest to orthostatic tilt will be associated with supine PWV in
3

high-level SCI and there will be no relationship among the change of renin from the supine rest
to orthostatic tilt with supine PWV in low-level SCI and controls.

4

Chapter II

LITERATURE REVIEW

A traumatic spinal cord injury (SCI) is a sudden devastating condition that affects a
person’s everyday activities and it has been estimated that there are approximately 17,730 new
cases of SCI each year in the United States (White & Black, 2016). An injury to the spine
interrupts neural transmission from cortical centers to destinations below the level of injury
(LOI), which may adversely impact regulation of the cardiovascular system by the autonomic
nervous system (ANS), which may be dependent on the LOI and the degree of motor and
sensory dysfunction (Garstang & Miller-Smith, 2007; Kirshblum & Campagnolo, 2011; West,
Mills, & Krassioukov, 2012). Improvements in acute and sub-acute care post injury have resulted
in increased life expectancy for individuals with SCI, contributing to increased risk of ageassociated disorders including cardiovascular disease (CVD), which is a leading cause of
mortality and morbidity in individuals with chronic SCI (Myers, Lee & Kiratli, 2007). Arterial
stiffness (AS) is one of the earliest detectable indicators of changes in vascular remodeling which
may be a predictor of CVD progression (Balta et al., 2014; Cavalcante, Lima, Redheuil, & AlMallah, 2011; Stéphane Laurent & Boutouyrie, 2007; Vlachopoulos, Aznaouridis, & Stefanadis,
2010). Understanding the underpinnings of CVD in this population by measuring AS can help
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clinicians more effectively screen and detect individuals with SCI at increased risk thereby
preserving cardiovascular health and longevity.
An intact spinal cord is responsible for transmitting neuronal signals from the periphery
to the brain and back to properly regulate sensory, motor and autonomic function (Nógrádi &
Vrbová, 2006). This multifaceted network of neurons is critically dependent on connection to the
brain and cannot function appropriately under circumstances of partial or complete cortical
disconnection (Nógrádi & Vrbová, 2006). The nervous system is divided into central and
peripheral nervous systems. The central nervous system (CNS) includes the brain and spinal cord
(Robertson, Low, & Polinsky, 2011). The peripheral nervous system is comprised of the somatic,
enteric, and ANS, each controlling specific aspects of organ function. The somatic nervous
system regulates voluntary movement in the skeletal muscles and responds to sensory feedback
from afferent peripheral nerve transmission (Brodal, 2004). The enteric nervous system controls
function of the gastrointestinal tract (esophagus, stomach and intestines) and is thought to
coordinate and direct the functions of the digestive system (Furness, 2006).
The ANS has two branches, the sympathetic nervous system (SNS) and the
parasympathetic nervous system (PNS), which regulate the cardiovascular system controlling
hemodyanmic function including blood pressure (BP), heart rate (HR) (Kirshblum &
Campagnolo, 2011), coronary blood flow and peripheral vasomotor tone (Garstang & MillerSmith, 2007; West et al., 2012) on a beat-by-beat basis. The ANS regulates these functions in
response to afferent feedback from the periphery by altering neural efferent transmission to alter
cardiac chronotropy (HR) and inotropy (myocardial contractility) as well as peripheral
vasomotor tone (Garstang & Miller-Smith, 2007). While both the SNS and PNS are actively
involved in cardiovascular regulation, the PNS is primarily involved in modulating cardiac
6

chronotropy through direct innervation of the sinoatrial node (SA-node), whereas the SNS
controls cardiac rate and contractility as well as vascular tone (Kirshblum & Campagnolo, 2011).
SNS control originates in the rostroventrolateral medulla (RVLM) and modulates the
cardiovascular system through sympathetic preganglionic neurons, which stem from the 1st
thoracic vertebra (T1) to the 2nd lumbar vertebra (L2) (Kirshblum & Campagnolo, 2011). Preganglionic sympathetic nerve fibers travel on to the postganglionic neurons which directly
innervate target organs resulting in an increase in peripheral SNS activity (Phillips &
Krassioukov, 2015). Origin of SNS innervation to the heart and the upper extremity vasculature
is from T1-T4, whereas, SNS innervation to the blood vessels of the splanchnic bed and lower
extremity originates at spinal segments T6-T12 (Kirshblum & Campagnolo, 2011). Control over
the blood volume in the vascular bed regulate stroke volume and cardiac output, which controls
arterial BP (Kirshblum & Campagnolo, 2011).Thus, the LOI may play a direct role in altering
SNS cardiovascular regulation. On the contrary, origin of PNS cardiovascular innervation is
through the vagus nerve and cranial nerve X which exits the brain stem above the cervical spine.
Therefore, SCI does not anatomically alter PNS cardiac innervation although functional
impairment may be evident (Krassioukov et al., 2012).
The spinal cord receives sensory information from somatic and visceral receptors through
afferent nerves and transmits this information to supraspinal regulatory centers through
ascending tracts. The brain structures then transmit these signals to muscle and organ targets
sites through the efferent nerves (Campagnolo, Kirshblum, Nash, Heary, & Gorman, 2011). SCI
affects the somatic nervous system because the conduction of sensory and motor signals cannot
transmit across the site of lesion appropriately (Kirshblum et al., 2011); thus, it is important to
classify these individuals into a sensory and motor level by assessing dermatome, area of skin
7

innervated by sensory axons, and myotomes, muscle fibers innervated by the motor axons
(Kirshblum et al., 2011). The American Spinal Injury Association (ASIA) provides a more
precise approach to grade the degree of motor and sensory impairment (Kirshblum et al., 2011).
Complete motor and sensory injury are classified as ASIA impairment scale (AIS) A and is
defined as having no sensory or motor function below the neurological LOI. AIS B, C and D are
considered incomplete injuries, which have some partial preservation of sensory (AIS B) and/or
motor function (AIS C & D) below the lesion level (Kirshblum et al., 2011). Physiologic
changes are directly related to the level and completeness of motor and sensory injury with
greater impairments in individuals with higher level and more complete lesions (Kirshblum &
Campagnolo, 2011); however, the level of ANS impairment may not relate to AISA
classification of motor and sensory impairment (Krassioukov et al., 2012).
After a SCI, descending sympathetic preganglionlic neurons are disrupted causing loss of
supraspinal regulation of cardiovascular function (Kirshblum & Campagnolo, 2011; Phillips,
Krassioukov, Ainslie, & Warburton, 2012), resulting in a reduction or absence of autonomic
cardiovascular control that may be directly related to the LOI and severity of trauma to the cord
(Garstang & Miller-Smith, 2007; S. Kirshblum & Campagnolo, 2011; West et al., 2012). After a
high-level injury (T1 and above), there is interruption of the descending signals from the medulla
to the thoracic spinal cord thereby altering SNS, but preserving PNS cardiovascular control
(Garstang & Miller-Smith, 2007; Krassioukov, Warburton, Teasell, Eng, & Team, 2009;
Partida, Mironets, Hou, & Tom, 2016; Phillips & Krassioukov, 2015; West, Alyahya, Laher, &
Krassioukov, 2013), which results in resting hypotension, orthostatic hypotension (OH) and
episodes of extreme high and low BP (Kirshblum & Campagnolo, 2011; Krassioukov et al.,
2009; Krassioukov, Karlsson, Wecht, & Wuermser, 2007; Phillips & Krassioukov, 2015; Wecht
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& Bauman, 2013; West et al., 2013). Another name for individuals with high cord injuries is
tetraplegic, which refers to an injury to the cervical spine and results in motor, sensory and ANS
impairment of the upper and lower extremity, the truck and pelvic organs ( Kirshblum et al.,
2011). Although there is interruption between the sympatho-excitatory pathways from the
brainstem to the sympathetic preganglionic neurons, hypotensive individuals with tetraplegia
remain clinically asymptomatic (no symptoms of dizziness, blurred vision, light-headedness,
etc.) (Handrakis et al., 2009; Wecht et al., 2011; Wecht, Rosado-Rivera, Handrakis, Radulovic,
& Bauman, 2010). Support of the renin-angiotensin-aldosterone system (RAAS) is believed to be
upregulated and adequately compensates for the lack of SNS vascular control in this population
(Handrakis et al., 2009; Popa et al., 2010; Wecht & Bauman, 2018; Wecht et al., 2011; Wecht et
al., 2010).
The RAAS plays an essential role in maintaining long-term BP and has been detected in
tissues such as heart, kidney, peripheral vasculature and the brain (Aroor et al., 2014; DeMello &
Frohlich, 2009). In uninjured controls, when the baroreceptors sense a decrease in BP and blood
volume, the kidneys release renin, primarily by the juxtaglomerular cells, to activate the RAAS
(DeMello & Frohlich, 2009). This system is an enzymatic cascade in which renin is released
into the blood and acts on angiotensinogen to form angiotensin I, which forms angiotensin II
(ANG II) by the angiotensin converting enzyme (ACE) (Bandeira, Gharib, Golbert, Griz, &
Faria, 2013; DeMello & Frohlich, 2009; Gordan, Gwathmey, & Xie, 2015). ANG II is a potent
vasoconstrictor primarily by increasing BP and secondarily by increasing retention of sodium
and water and by stimulating aldosterone release from adrenal glands (DeMello & Frohlich,
2009). Recent evidence has suggested that ANG II not only plays a role in cardiovascular
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physiology, but also may contribute to cardiovascular pathophysiology (Husain, Hernandez,
Ansari, & Ferder, 2015; Mehta & Griendling, 2007; Zhong et al., 2010).
Despite the important benefits of the RAAS in regulating BP homeostasis, there is recent
evidence that chronic overproduction of ANG II may result in remodeling and restructuring of
peripheral and coronary blood vessels, heart and the kidneys by augmenting the generation of
reactive oxygen species, a main molecule responsible for inflammation (Duprez, 2006; Weir &
Rolfe, 2010). ANG II has been shown to create oxidative stress in vessel walls, and enhance
production of inflammation, thrombosis and fibrosis specifically on vascular smooth muscle cells
and endothelial cells (Duprez, 2006). Additionally, ANG II is a major contributor in profibrotic
mechanisms including increasing the production of matrix metalloproteinases, which modulate
collagen and elastin turnover in the vascular wall (Duprez, 2006). All of these adverse effects
may result in chronic inflammation of vessel walls, which is a major facet of atherosclerosis (El
Bekay et al., 2003). Recent evidence has demonstrated that the use of ACE inhibitors or ANG II
receptor blockers (ARBs) reduce vascular remodeling (Mahmud & Feely, 2000; Shahin, Khan,
& Chetter, 2012; Yusuf et al., 2000), and moreover, the use of ARBs have been shown to
decrease vasculature stiffness independent of BP (Karalliedde et al., 2008; Azra Mahmud &
Feely, 2004; Shahin et al., 2012). Using ARBs has been shown to reduce collagen production
and increase the elastin to collagen ratio (Shahin et al., 2012). A meta-analysis demonstrated that
the use of ARBs and ACE inhibitors reduced the risk of myocardial infarction, stroke,
cardiovascular mortality and total mortality in uninjured subjects (Reboldi et al., 2008),
suggesting that the excessive ANG II production may lead to an increased risk of CVD.
CVD has developed as a leading cause of mortality in individuals with chronic SCI and;
furthermore, morbidity due to CVD occurs at an earlier age in the SCI compared to the uninjured
10

population (Jonathan Myers, Matthew Lee, & Jenny Kiratli, 2007). In the general population,
CVD risk is attributed to age, hypertension, physical (in)activity level, body composition and
dyslipidemia (Cragg, Noonan, Krassioukov, & Borisoff, 2013; Sowers, Epstein, & Frohlich,
2001); however, there is evidence to suggest that these risk factors do not fully explain the
increased incidence of CVD in the SCI population (Cragg et al., 2013). A possible, previously
not considered, risk factor for this population could be the overuse of ANG II, since individuals
with SCI have a heightened reliance on the RAAS to maintain BP homeostasis (Mathias,
Christensen, Frankel, & Peart, 1980; Mathias, Frankel, Davies, James, & Peart, 1981; Wecht et
al., 2005). Renin was shown to be higher during resting conditions in individuals with SCI
compared to uninjured controls, indicating that upregulation of the RAAS is not dependent on
the integrity of the SNS (Johnson, Park, & Frankel, 1971; Mathias et al., 1975; Mathias et al.,
1980; Mathias et al., 1981). Goothius and colleagues (2010) demonstrated an increase in ANG II
during baseline in SCI compared to uninjured controls, however, ANG II levels were not
excessively high (Groothuis et al., 2010). Additionally, their results showed that ANG II
explained increased leg vascular resistance, but not forearm resistance, which may be because
AT 1 receptors have increased sensitivity or density in the legs compared to the arms (Groothuis
et al., 2010). This concept was further studied in rats with a chronic spinal transection at T11
demonstrating increased reactivity of vascular muscle to ANG II (Al Dera & Brock, 2014). Due
to dysfunction of supraspinal SNS regulation to the peripheral vasculature, the RAAS may play a
greater role in regulating vascular resistance (Al Dera & Brock, 2014) for maintenance of BP
homeostasis.
The ANS is responsible for postural homeostasis; therefore, with impairment to the
system, BP will fall after moving to an upright position (Fedorowski et al., 2009). According to a
11

Consensus statement from the American Autonomic Society and American Academy of
Neurology, OH is defined as a decrease in systolic BP (SBP) of 20+ mmHg and/or a fall in
diastolic BP (DBP) of 10+ mmHg within 3-minutes of moving from supine to the upright
position, with or without symptoms (Neurology, 1996). In an uninjured person, movement to the
upright position reduces BP due to pooling of blood in the lower extremities. This is sensed by
the baroreceptors which elicit withdrawal of tonic vagal (PNS) tone to the SA-node and
activation of SNS vasomotor tone via descending spinal tracts, causing vasoconstriction and
increase in cardiac rate and contractility resulting in a rise in BP (Benvenuto & Krakoff, 2011;
Claydon, Steeves, & Krassioukov, 2006). In the uninjured population this quick feedback loop
results in non-significant changes in SBP, slight increases in DBP and a corresponding increase
in HR during an orthostatic challenge (Freeman et al., 2011).
After a SCI, the SNS arm of the baroreceptor reflex, is interrupted or lost, resulting in
alteration in orthostatic BP control (Claydon & Krassioukov, 2008; Phillips, Cote, Bredin,
Krassioukov, & Warburton, 2012). Generally, lesions above T6 experience orthostatic instability
due to SNS dysfunction, which leads to the inability to adequately adjust vasomotor tone and
maintain BP (Claydon et al., 2006). Individuals with injuries above T6 would be expected to
have some degree of impaired vascular innervation to the splanchnic bed and the lower
extremities, which holds a majority of blood volume (Garstang & Miller-Smith, 2007; Sahota,
Ravensbergen, McGrath, & Claydon, 2012). Additionally, the lack of skeletal muscle pump may
contribute to increased blood pooling in the lower extremities venous vasculature resulting in
lower venous return thereby restricting stroke volume (Claydon et al., 2006; Krassioukov &
Claydon, 2006). With higher LOI already demonstrating low resting BP (West et al., 2012), a
further decline in BP during orthostatic re-positioning can result in symptoms of cerebral
12

hypoperfusion including: dizziness, weakness, light-headedness, blurred vision, pre-syncope and
syncope, which can adversely impact the activities of daily living (Claydon et al., 2006; Garstang
& Miller-Smith, 2007; Phillips, Krassioukov, Ainslie, Cote, & Warburton, 2014).
Another facet of the underlying pathophysiology of OH following SCI is decreased
resting catecholamine levels. The SNS regulates the response of releasing circulating hormones
from the adrenal medulla (S. Kirshblum & Campagnolo, 2011, p. 138). Measuring free plasma
catecholamines correlates with SNS integrity due to their short half-life (Claydon, Hol, Eng, &
Krassioukov, 2006; Kirshblum & Campagnolo, 2011). Orthostatic BP responses are related to
circulating levels of norepinephrine (NE), and lower levels of NE are associated with an
increased incidence of OH in persons with SCI (Claydon & Krassioukov, 2008). Relevant
literature has shown decreased plasma epinephrine and NE concentration in individuals with
cervical lesions compared to individuals with thoracic injuries and uninjured controls
(Krassioukov et al., 2009; Mathias et al., 1975; Schmid, Huonker, Barturen, et al., 1998; Schmid,
Huonker, Stahl, et al., 1998). Specifically, after 10 minutes of an orthostatic challenge, NE
increased 14% in individuals with high cord lesions, compared to 115% increase in uninjured
controls (Mathias et al., 1975). Additionally, the investigators reported that epinephrine was
unaffected by the change in posture in individuals with cervical lesions (Mathias et al., 1975).
The small change in catecholamines after orthostatic repositioning in persons with tetraplegia is
due to impaired supraspinal control of the sympathetic efferent pathways (Mathias et al., 1980)
and consequently, results in the inability to increase vasomotor tone and maintain BP (V.
Claydon et al., 2006)
With a greater fall in BP during OH in individuals with tetraplegia, the use of the RAAS
is critically important to maintain BP; however, the pathological effects of ANG II may supplant
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the benefits. Renin was shown to increase in individuals with tetraplegia during head-up tilt
(HUT), an orthostatic challenge, at a much quicker and higher rise compared to uninjured
controls (Mathias et al., 1975; Mathias et al., 1981; Popa et al., 2010); conversely, one study
demonstrated that renin was not increased with HUT in individuals with tetraplegia, which the
investigator explained may be due to large inter-subject variability (5 of the 7 subjects were
motor and sensory incomplete) (Wecht et al., 2005). In individuals with cervical injuries, the use
of anti-hypotensive agents (midodrine and L-NAME) to normalize BP may reduce orthostatic
dependency on the RAAS because plasma renin and aldosterone levels after HUT were
comparable with supine levels during HUT and there was a significant inverse association
between mean arterial pressure and renin responses to HUT (Wecht et al., 2011). This finding
may have significant clinical implication because the level of dependency on the RAAS may be
reduced if BP is maintained during an orthostatic challenge (Katzelnick et al., 2017; Jill M
Wecht et al., 2011). Additionally, Groothuis et al. (2010) demonstrated that ANG II contributed
to increased supine leg vascular resistance in individuals with thoracic injuries (T4-T12) but did
not explain the increased vascular tone during 30°of HUT. This disparate finding may relate to
an insufficient orthostatic stress (30°) since higher degrees of HUT (45 and 60 degrees) have
been shown to place greater strain on SNS (Phillips et al., 2014; Steinback et al., 2005; Jill M
Wecht et al., 2009). Additional evidence is needed to demonstrate if renin and ANG II levels are
increased during an orthostatic provocation in persons with SCI and if so, how this might
contribute to increased vascular resistance and AS.
AS has been identified as an independent risk factor for CVD (Cavalcante et al., 2011; Azra
Mahmud & Feely, 2004; Shahin et al., 2012) and is one of the earliest detectable indicators of
adverse vascular changes (Cavalcante et al., 2011). The primary function of the arterial system is
14

to deliver blood from the heart to the peripheral tissues and to dampen intermittent left ventricle
ejection pressure thereby maintaining a steady flow of nutrient rich blood to vital organs
(London & Pannier, 2010). The ability of the arteries to accommodate changes in blood volume
during the cardiac cycle depends on the ratio of elastic to collagen fibers (Oliver & Webb, 2003).
In a more compliant arterial system, reflected waveforms return to the aorta from the periphery
during diastole, increasing DBP and augmenting coronary artery blood flow, which translates
into reduced AS. Conversely, in a relatively stiffer arterial system, due to increased collagen and
lumen diameter thickness (Duprez, 2006; Safar, Blacher, & Jankowski, 2011), reflective
waveforms return to the aorta during systole, thereby augmenting ventricular work, limiting
coronary artery perfusion and increasing AS (London & Pannier, 2010; Oliver & Webb, 2003).
In the general population, AS is influenced by two principal factors: age and BP (Cecelja &
Chowienczyk, 2009; Hansen, 2010; London & Pannier, 2010). Both elements cause elastic fibers
to spilt, fracture and become fragmented after repetitive stress cycles, and cause elastin fibers to
degenerate while collagen fibers increase. Stiffening of the vascular walls with aging is
associated with increased hemodynamic load, hormonal changes, glycemic diet and overall
decline in the structure and function of the vascular system (Shirwany & Zou, 2010).
Augmentation of AS with age occurs gradually and this trajectory is similar in males and females
(Benetos et al., 2002). A stiffening vasculature works to increase SBP by amplifying the initial
pressure wave generated during left ventricular ejection, accelerating return of the reflected
wave from the periphery during systole and, reducing pressure during diastole (London &
Pannier, 2010; Shirwany & Zou, 2010). This adversely impacts cardiac function by increasing
myocardial oxygen demand while hindering ventricular ejection and comprising coronary
perfusion (Benetos et al., 2002; London & Pannier, 2010).
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Vascular remodeling is largely accomplished within 3 weeks following SCI (C4-L1) and
these rapid changes include a 25% reduction in femoral artery diameter and lower extremity
blood volume, and doubling of shear stress rate (de Groot, Bleeker, van Kuppevelt, van der
Woude, & Hopman, 2006). Additionally, Thijseen and colleagues (2012) observed gradual
increases in arterial wall thickness within 24 weeks after injury which was present and similar
below (femoral artery) and above (carotid artery) the spinal lesion, demonstrating that arterial
wall thickness is systemic and not localized (Thijssen et al., 2012). Increased AS has been
documented in individuals with SCI compared to age-matched uninjured controls (Huang, MayKuen, et al., 2013; Katzelnick et al., 2017; Miyatani et al., 2009; Phillips et al., 2012; Thijssen et
al., 2012; Wecht, Weir, DeMeersman, Spungen, & Bauman, 2004); however, there is
controversy comparing stiffness in individuals with tetraplegia and paraplegia.
Increased AS was reported in individuals with thoracic cord lesions (T2-T12) compared to
those with high cord lesions (C2-C8) (Miyatani et al., 2014). This finding is surprising because
most of the risk factors (BP lability, deconditioning and impaired SNS) for increased central AS
is reduced in those with paraplegia individuals (Popa et al., 2010; Claydon et al., 2006; West
2012), but may be contributable to categorical segregation by level of motor impairment (i.e.,
paraplegia versus tetraplegia) rather than by level of sympathetic cardiovascular interruption (
i.e., above versus below T6). Another study reported no difference in AS between individuals
with high and low cord lesions, which may be due to variability in duration of injury (3 to 518
months) (Wu et al., 2017). Recently, our group was the first to document heightened stiffness in
high cord lesion (C3-T5) compared to low thoracic lesions (T7-T12) (Katzelnick et al., 2017). In
this study, we measured AS by augmentation index at the radial artery, whereas in the prior
report (Miyatani et al., 2014) PWV was determined at the carotid to the femoral artery.
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Individuals with low cord lesions would be expected to have full sympathetic innervation of the
radial artery, compared to individuals with high cord lesions who have partially to complete
decentralized autonomic control. Further investigation is needed to clarify and ascertain the
relationship between lesion level and AS.
There is evidence supporting a direct linear association between AS and LOI, with AS
increasing with ascending LOI (Katzelnick et al., 2017). In this same study, the investigators
reported that individuals with increased AS reported experiencing OH (Katzelnick et al., 2017);
and furthermore, Currie et al. (2019) demonstrated that hypotensive events within 24-hour period
were associated with increased arterial stiffness in individuals with injuries to T6 and above.
This suggests that BP instability may play a role in causing structural vascular adaptations AS
post SCI (Currie et al., 2019; Phillips et al., 2014). A recent study demonstrated increased AS
during HUT in individuals with cervical injuries compared to uninjured controls (Phillips et al.,
2014); conversely, Huang and colleagues (2013) showed no significant group difference in AS in
a similar study design (Huang, Wong, et al., 2013). This discrepancy may be due to the
differences in duration of injury (5-144 weeks vs. 3-289 months) and completeness of injury
(Phillips et al. all motor complete (AIS A & B) vs. Huang et al. AIS A, B, C & D). Interestingly,
our team recently demonstrated that there was significant inverse relationship between seated
SBP and AS (Katzelnick et al., 2017); and furthermore, Phillips et al. (2014) demonstrated that
the increase in AS during HUT in SCI was reversed by a pre-treatment of midodrine
hydrochloride, an alpha-adrenergic agonist. We speculate that this may be related to a reliance on
RAAS for orthostatic BP maintenance, which may have detrimental effects on AS. Although
increased AS has been reported in individuals with SCI, controversy abounds and additional
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evidence is needed to gain a better understanding of impact of morphologic and physiologic
vascular adaptations that occur following SCI on orthostatic BP regulation and AS.
A variety of non-invasive testing modalities are used to accurately assess and track AS
(Jae, Heffernan, Lee, & Fernhall, 2008). Ultrasound techniques can be used to assess vessel
distention and derived stiffness indexes or flow waveforms (Townsend et al., 2015). These
modalities (i.e. flow mediated dilation, carotid intima-media thickness) are generally more
expensive and require a high level of technical skill (Stoner, Credeur, Dolbow, & Gater, 2015).
MRI-based approaches can examine almost any vessel and provide more accurate distance and
area measurements, but these approaches are very expensive and impractical (Townsend et al.,
2015). Applanation tonometry has been used extensively in the literature because it is relatively
inexpensive, requires a short testing time, and does not demand highly technical skill levels
(Stoner et al., 2015; Townsend et al., 2015). Pulse wave velocity (PWV), which may be assessed
using applanation tonometry, is calculated by measuring the distance between two vessels (i.e.
carotid, brachial, radial, femoral, ankle) and the pulse wave arrival time at each vessel (R wave
of ECG) (Stoner et al., 2015).
Assessment of aortic PWV (aPWV, using the carotid and femoral arteries) is considered
to be the gold standard technique (Townsend et al., 2015) because of its high reliability and
validity. Using the SphygmoCor CPV system (AtCor Medical Pty Ltd., West Ryde, NSW.,
Australia), aPWV was validated against invasive measurement of aPWV from the ascending
aorta to the iliac bifurcation in 135 participants (Weber et al., 2009). The mean difference
between the invasive aPWV and noninvasive aPWV was -0.2 m/s, (Spearman’s R = 0.73,
p<0.0001) (Weber et al., 2009). Additionally, the reproducibility of the system for withinobserver variability was 0.07 ± 1.7 m/s and for between-observer difference was 0.30 ± 1.25 m/s
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(Wilkinson et al., 1998). Measuring aPWV along the aortic and aorto-iliac pathway is most
appropriate because the aorta is the principal cushioning artery and is responsible for the
pathophysiological effects of AS (Stephane Laurent et al., 2006; London & Pannier, 2010).
Summation and Relevance
In summary, medical advances have contributed to increased life expectancy in
individuals with SCI; however, CVD has become a leading cause of morbidity and mortality in
individuals with chronic SCI (Cragg et al., 2013; Krause, Cao, DeVivo, & DiPiro, 2016; LaVela
et al., 2012). Predominantly sedentary lifestyles (Stoner et al., 2015), ANS dysfunction (Cragg et
al., 2013) and heightened inflammatory processes (LaVela et al., 2012) may contribute to the
increased incidence and premature development of CVD in the SCI compared to the uninjured
population (Myers, Lee, & Kiratli, 2007). It is well recognized that CVD risk increases with age,
hypertension, adverse body compositional changes and physical inactivity; however, there is
support to suggest that these traditional risk factors may not fully explain the early onset of CVD
in the SCI population (Cragg et al., 2013; Miyatani et al., 2014). In fact, it has been demonstrated
that PWV was increased in SCI participants compared to healthy uninjured controls after
matching for age, body composition and activity levels (Phillips et al., 2014). Additionally,
individuals with tetraplegia demonstrated heightened CCA intima-media thickness compared to
individuals with paraplegia, even with similar inflammatory profile (Matos-Souza et al., 2010).
Both of these studies suggests that other factors may mediate increases in AS in SCI population,
and specifically, individuals with high-level injuries.
Individuals with tetraplegia rely heavily on the RAAS for both short- and long-term
regulation of orthostatic BP ( Wecht et al., 2011), which may play an important role in
determining AS in this population (Katzelnick et al., 2017; West et al., 2013). However, the
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association between ANG II levels and AS during an orthostatic provocation has not been
studied in the SCI population. Understanding the contribution of activation of the RAAS and
elevated levels of ANG II to the development of premature and heightened AS in the SCI
population will guide clinical treatment of hypotension and OH, which may lead to improved BP
regulation and preservation of cardiovascular health and longevity.
Theoretical Framework
Asymptomatic OH occurs in up to 50% of individuals with chronic tetraplegia (
Krassioukov et al., 2009; Phillips et al., 2012) and may lead to pre-syncopal symptoms that
include light-headedness, dizziness, blurred vision, fatigue, nausea, dyspnea, which adversely
impacts their quality of life, hindering their ability to perform orthostatic maneuvers during
routine daily activities and mobilization (Claydon et al., 2006; Krassioukov et al., 2009; Phillips
et al., 2012). Uninjured individuals with persistent and episodic OH have been shown to be at an
elevated risk of stroke (Benvenuto & Krakoff, 2011; Eigenbrodt et al., 2000), and it has been
speculated that OH may explain the 2-3 fold increase of stroke in the SCI population (Cragg et
al., 2013; Phillips et al., 2012). Additionally, OH is associated with cognitive deficits in the
uninjured population (Novak & Hajjar, 2010; Yap, Niti, Yap, & Ng, 2008), which may
contribute to, in addition to chronic hypotension, documented deficits in memory, attention,
processing speed, and executive function in hypotensive individuals with SCI (Jegede et al.,
2010; Wecht et al., 2011). Several large population-based studies reported increased AS may
contribute to cognitive decline with aging in the uninjured population (Pase et al., 2010).
Specifically, three studies have documented that association between increased AS and cognitive
decline in global cognitive function (mini-mental state examination score) after co-varying for
age, MAP (mean arterial pressure), education level, and CVD (Elias et al., 2009; Scuteri et al.,
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2007), as well as in verbal learning, delayed recall, and memory (Waldstein et al., 2008). Thus,
premature changes in vascular morphology may predispose individuals with SCI to cognitive
deficits. Furthermore, increasing vascular stiffness is associated with an increased risk of CVD
in the general population (Cecelja & Chowienczyk, 2012; Mitchell et al., 2010; Vlachopoulos et
al., 2010). Recent literature reported that more rostral level and more complete SCI are
associated with greater risk of all CVD (Groah, Weitzenkamp, Sett, Soni, & Savic, 2001). It is
imperative that we identify the possible association between increased reliance on the RAAS for
BP maintenance and the increased incidence of AS in persons with SCI with the goal of reducing
CVD progression and improving cognitive function in this highly vulnerable population.
Gaps
Based on recent literature and our theoretical model, convincing evidence is needed to
demonstrate that liberal use of anti-hypotensive medications in individuals with SCI might
mitigate reliance on the RAAS and reducing levels of ANG II during orthostasis. Using this type
of medication would expect to improve BP homeostasis, thereby lessening the symptoms
associated with cerebral hypoperfusion and improving long-term cardiovascular and cognitive
outcomes. As of today, clinical practice guidelines recommend that only individuals who
experience symptomatic OH be prescribed anti-hypotensive medications; however, the
homeostatic maintenance of BP, regardless of symptoms, may be critical in promoting long-term
health and independence in the SCI population. Secondly, sufficient evidence is lacking to
describe the association between orthostatic BP changes and the increased incidence of AS in the
SCI population. Investigation into this association have consisted of heterogeneous study
subjects with varying levels, severities and durations of injury, which would be expected to
differentially impact the SNS response to orthostasis. Adequate plasms catecholamine responses
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during HUT would improve orthostatic BP responses thereby limiting use of the RAAS.
Moreover, during the acute phase of SCI (<1 years post injury), the morphology of the arterial
vessels is changing rapidly; therefore, it may be more effective to measure AS after the initial
paralysis and atrophy of the muscles. Lastly, there is no research demonstrating if the overuse of
RAAS, specifically ANG II, contributes to the increased AS in the SCI population. Recent
literature has stated that there may be additional risk factors other than the traditional ones that
explain the increased CVD in this population, thus the over production of ANG II may explain
the morphologic vascular mal-adaptations that occur following a SCI.
Scientific Relevance
A heightened prevalence of CVD is now the leading cause of morbidity and mortality in
the SCI population, and ANS dysfunction underlines several irregularities that contribute to
CVD (Myers et al., 2007). It has been speculated that persons with chronic SCI have accelerated
cardiovascular aging (Myers et al., 2007; Yarar-Fisher et al., 2017) due to sedentary lifestyle
(Stoner et al., 2015), increased inflammatory processes (La Favor, Hollis, Mokshagundam, &
Olive, 2011; Sherri L LaVela et al., 2012), and cardiovascular autonomic dysregulation (.
Claydon & Krassioukov, 2008; Cragg et al., 2013; Myers et al., 2007; Nier & Hansen, 2017).
Recent literature speculates that additional risk factors are likely to contribute to premature CVD
in the SCI population, and it has been shown that individuals with SCI have a 2 to 3 fold increase
in the odds of developing heart disease and stroke (Cragg et al., 2013). Additionally, in the
general population, a 1.0 m/s increase in aPWV translates to a 15% increase in CVD risk
(Vlachopoulos et al., 2010) and consistent evidence demonstrates that individuals with SCI have
an accelerated aPWV that is increased 2-3 m/s compared to uninjured individuals (Lee, Phillips,
& Krassioukov, 2017; Miyatani et al., 2009; Phillips et al., 2012). Thus, it cannot be over
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emphasized that health care providers are faced with significant challenges associated with
prevention, diagnosis and management of older individuals with SCI at heightened risk for
development of chronic diseases (Groah et al., 2001). Identifying the potential contribution of
increased reliance on the RAAS, and ANG II, for orthostatic BP hemostasis in the SCI
population and the effect on AS will help clinicians understand and screen for additional risk
factors that contribute to CVD.
Summary
As a consequence of decentralized SNS, individuals with high level lesions are
hypotensive with episodic falls in BP during orthostasis (Kirshblum & Campagnolo, 2011; A.
Krassioukov, 2009). OH after SCI is thought to be related to baroreflex dysfunction, reduced
skeletal muscle pump, and diminished catecholamines, which leads to an increased reliance on
the RAAS for BP maintenance (S. Kirshblum & Campagnolo, 2011; Jill Maria Wecht &
Bauman, 2018). The RAAS has been increasingly recognized as a major risk factor in the
progression of atherosclerosis and increasing CVD risk in the uninjured population (Williams,
2001). Specifically, ANG II has been shown to modify the structure of the arteries by altering the
ratio of collagen and elastic fibers in the vasculature (Shahin et al., 2012). Therefore, due to
increased dependency on the RAAS to maintain orthostatic BP homeostasis (Wecht & Bauman,
2018), individuals with SCI, particularly those with high cord lesions, may be at increased risk
for premature and increased AS.
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Chapter III

METHODS

Participants
All subjects (N=33) were between the ages of 28-69 years with no known history of
CVD, diabetes mellitus, and hypertension. All were current nonsmokers for a minimum of 1 year
before investigation and were not receiving medications known to affect autonomic
cardiovascular function. Subjects with high-level injury (HIGH-SCI; n=11; C4-T1) and lowthoracic injury (LOW-SCI; n=11; T6-12) were injured for at least 1 year, chronically wheelchair
bound, and ASIA grade A, B or C. The uninjured control subjects (n=11) were matched for age,
height, and weight to the subjects with SCI.
Individuals with SCI will be recruited from the Northern New Jersey SCI Model System
database, which currently contains over 1000 people with traumatic SCI. Additionally, uninjured
control subjects were recruited from the local community and hospital personnel via study
solicitation flyer distribution. Participants were screened before study for inclusion and exclusion
criteria. The Institutional Review Board for Human Studies of Seton Hall University, James J.
Peters Veterans Affairs Medical Center and Kessler Foundation granted approval for the study,
and informed consent was obtained before study initiation.
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Procedure
All subjects were told to avoid caffeine, alcohol and exercise for at least 12 hours before
testing and to be well hydrated. Participants were asked to remain seated in a testing chair to
collect 5 minutes of seated resting hemodynamic data. After, subjects were asked to transfer to
the tilt table and remained in the supine position for 10 minutes prior to baseline supine
hemodynamic measurement, PWV, and first blood draw. Subjects were then progressively tilted
from supine to 30 º, 45 º, and 60 º for 10 minutes at each tilt. A 3-lead ECG (Impedance
Pneumograph, model RESP 1: UFI, Morro Bay, CA, USA) was used to monitor beat-to-beat HR,
with ECG electrodes placed at the right and left mid-axillary lines in the 5th intercostal space and
at the right anterior axillary line. Before placing each electrode, each site was cleaned with
alcohol pads. Continuous BP was assessed at the finger using photoplethysmograph (Finometer
PRO, Finapres Medical Systems B. V., Netherlands) and at the brachial artery with manual
auscultation (Series Wall Mobile Sphygmomanometers, Trimline Medical Products, Raritan, NJ,
USA). Mean arterial pressure (MAP) was calculated as diastolic blood pressure (DBP) +
1/3(SBP-DBP). Continuous HR and BP were viewed and monitored in real-time and were stored
on a desktop hard drive for offline analysis. HR and BP signals were collected at a sample rate of
500 Hz/channel with a 12-bit analog-to-digital converter (DAQcard-700, National Instruments,
Austin, TX) and were analyzed using customized programs written with LabVIEW graphical
software for instrumentation (National Instruments). In each position and tilt angle, HR and BP
were measured and averaged over 5 minutes to use for analysis. At 60 º, second blood draw was
collected.
Tilt Table
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The tilt table was padded and motorized. Restraining straps were used on the lower
extremities and trunk to ensure subject safety during higher inclinations of HUT and to avoid
lower-extremity muscle contractions in the control subjects. The straps were wide and padded for
subject comfort and to insure that stimulation of sympathetic spinal reflexes was not evoked. The
orthostatic provocation included a progressive HUT from supine position to 30º, 45 º and 60 º for
10 minutes at each angle of tilt. Adjustment of the tilt table to each angle was accomplished in
less than 5 seconds, and subjects were questioned at each angle of tilt regarding symptoms of
syncope (i.e., blurry vision, dizziness, light-headedness, or nausea).
Pulse Wave Velocity
After supine hemodynamic recording, PWV was measured using the SphygmoCor CPV
system (AtCor Medical Pty Ltd., West Ryde, NSW., Australia) at the carotid and femoral sites.
The average 5-minute resting supine BP was entered into the software. A 3-lead ECG designed
for the system measured the R-R wave with the ECG electrodes located just below the suprasternal notch, on the chest over the sternum and just above the left hip on the chest. The carotid
and femoral arteries were palpated for the strongest pulse and then measured from the
participant’s supra-sternal notch to each artery. The PWV measurement was taken in two steps:
a tonometry reading of site A (carotid artery) with an ECG signal simultaneously recorded
captured after 10 seconds of good data, followed by a 10 second reading of site B (femoral
artery) with an ECG signal (Research Applications Manual). Good quality PWV measurement
was accepted if the standard deviation was low, defined as the difference in HR between site A
and B measurements more than 5 beats per minute.
Hormonal Assessments
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Active plasma renin (surrogate measure of ANG II) and norepinephrine levels were
assessed by immunoassay. Antecubital venous blood samples were collected at supine and at the
60 º. Blood samples were immediately placed in an ice bath for subsequent centrifugation.
Plasma and serum were separated from blood products and frozen at -30 º for subsequent batched
analysis.
Data Analysis
Statistical analyses were performed using SPSS 16.0 (SPSS, Inc., Chicago, Illinois, USA)
software. All continuous variables were reported as mean plus or minus standard deviation
(mean ± standard deviation), unless otherwise stated. Data were assessed for normality using
Kolmogorov-Smirnov test and P-P plots. Pearson or Spearman’s corrleations for normal and
non-normal distributed data were used to examine if there was an influence of change of
orthostatic SBP on the RAAS responses to orthostasis and relationship between PWV and
change in renin. Univariate analysis of variance (ANOVA) were used to determine group
differences in hemodynamics, orthostatic reliance on the RAAS hormonal assessment (renin) and
supine PWV. Tukey HSD post hoc tests were used if the omnibus interaction effect was
significant. The level of statistical significance was set at α less than 0.05.
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Chapter IV

RESULTS & DISCUSSION

The first aim was to determine group differences in hemodynamics and hormone
concentrations among the groups. We hypothesized that SBP would decrease during HUT in
HIGH-SCI, while SBP would remain unchanged during HUT in LOW-SCI and able-bodied
controls. In addition, we predict that plasma renin levels will be significantly greater at HUT in
HIGH-SCI compared to LOW-SCI and able-bodied controls.
Our second aim was to investigate group differences for change in hemodynamics and
hormones from supine rest to 60-degree HUT. We hypothesized that individuals with HIGH-SCI
would have a greater change in SBP compared to LOW-SCI and able-bodied controls. Similarly,
we hypothesized that HIGH-SCI group would have an increased change in renin levels, while
renin levels would be unchanged in LOW-SCI and able-bodied controls.
Thirdly, we investigated the influence of the change in BP and change in plasma renin
from supine rest to 60-degree HUT. We hypothesized that individuals with HIGH-SCI would
have a positive relationship between the change in BP and change in renin, while there would be
no relationship between the two variables in the LOW-SCI group and able-bodied controls.
Lastly, we aimed to determine if increased reliance on the RAAS for orthostatic BP
regulation contributes to differences in AS. We hypothesized that there would be a positive
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relationship between change in renin and AS in HIGH-SCI, while there would be no relationship
between the two variables in LOW-SCI and able-bodied controls.
Participant Characteristics
The demographics of the study sample are presented by group (Table 1). The groups did
not differ significantly for age, height, weight or body mass index. In addition, the SCI groups
did not differ in AIS, DOI and age at time of injury.
Hemodynamics
Two-way ANOVA models were used to determine main and interaction effects for group
(able-bodied controls, HIGH-SCI, LOW-SCI) and orthostatic position (supine, HUT) in
hemodynamics and plasma renin.
Heart Rate
There were significant main effects for group (F(2,120)= 5.90, p=.01, ω2= .05) and
position (F(3,120)= 11.69, p<.001, ω2= .19); however, the interaction effect was not significant.
Systolic Blood Pressure
While the main effect for group was significant ((F(2,120)= 6.48, p=.002, ω2=.07); the
main effect for position and the interaction effects were not significant
Diastolic Blood Pressure
There was a significant group main effect (F(2,120)= 11.51, p<.0001, ω2=.14); however,
the main effect for position and the interaction effect were not significant.
Plasma Renin Responses
There was no significant main or interaction effects for plasma renin.
Arterial Stiffness
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One-way ANOVA was used to determine a significant group main effect for the AS
(p<.0001; eta2 (η2) =0.67). Pairwise comparisons (Tukey HSD procedure) indicated that AS was
significantly increased in HIGH-SCI (HIGH-SCI: 8.81 ± 1.91 m/s) and LOW-SCI (LOW-SCI:
7.36 ± 1.58 m/s) groups compared to age-matched controls (5.53 ± 0.95 m/s; p=.04). AS was
higher in the HIGH-SCI group compared to LOW-SCI; however, not significantly different.
Linear regression models were used to determine the effect of age and injury
characteristics on PWV among the groups. Although age did not contribute significantly to
PWV in the groups with SCI, age accounted for 83% of the variance in PWV in the control
group (r2=0.83; p=.002); In addition, there was no relationship between DOI, level of lesion and
AS in SCI groups,
Change in Hormonal Response
There was a significant main effect for the change in renin from supine to 60 degree
HUT, F(2,30)=6.31, p=.01, ω2=.25. Pairwise comparisons (Tukey HSD procedure) indicated
that individuals with HIGH-SCI had significantly higher changes in renin levels (11.54 ± 12.49
pg/ml) compared to individuals with LOW-SCI (0.47 ± 5.67 pg/ml, p=.01) and able-bodied
controls (1.22 ± 3.45 pg/ml, p=.02).
Orthostatic BP and Renin
Multiple regression analysis on the change in SBP and plasma renin was performed in the
total study sample (n=33). The results suggest that the model significantly improved our ability
to predict SBP, F(2,30)=7.61, p=.002. Change in renin was a significant predictor to the change
in SBP and contributed to the model, t(30)=-3.90, p<.001; however, the group predictor is not
significant and did not contribute to the model, t(30)=0.26, p=.80. The change in plasma renin
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accounted for 35% of the variance in the changes in SBP with tilt in the total study sample (r2=
0.347; p=.002).
Arterial Stiffness and Renin
Multiple regression analysis on AS and change in renin was performed in the total study
sample (n=33). Assumptions were met to perform multiple regression. The results suggest that
the model significantly improved our ability to predict AS, F(2,30)=19.66, p<.0001. The group,
t(30)=3.32, p=.002, and change in renin, t(30)=5.42, p<.0001 were significant predictors to AS
and contributed to the model. Relationship between change in plasma renin and AS was
significant in the total study sample (r2= 0.57; p<.0001).
Separate regression analysis by group were then used. Assumptions were met to perform
Pearson’s correlation for all three groups. As hypothesized there was a significant relationship
between AS and change in plasma renin in HIGH-SCI, r = .62, p =.04, while there was no
relationship in able-bodied controls, r=.04, p= .91.
For LOW-SCI, we performed Grubb’s test to identify an outlier in the group. The
absolute z score of the change in renin (2.91) was significantly higher than the upper significance
levels at sample size 11, so that score is an outlier (Grubbs & Beck, 1972). There was no
significant relationship between the AS and change in plasma renin in individuals with LOWSCI, r=.18, p=.62.
Discussion
As per design, the controls were age, height, weight and body mass index matched to the
SCI participants. In the present study, AS was measured by PWV, and was compared in agematched individuals with HIGH-SCI, LOW-SCI and able-bodied controls. AS was increased in
those with SCI compared to the uninjured controls; however, there were no differences in AS in
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the SCI groups. Secondly, the change in orthostatic BP from rest to 60-degree HUT was
inversely associated to the change in plasma renin levels in the total sample. Furthermore, the
change in plasma renin levels during HUT was directly related to AS in the HIGH-SCI group.
Arterial Stiffness by Group
It is well appreciated that the natural aging process increases AS, and the values of AS in
the control group were similar to those previously reported for healthy individuals (Boutouyrie
and Vermeersch, 2010). However, the association between age and AS was not significant in our
participants with SCI, regardless of the level of lesion, which is in agreement with our previous
study (Katzelnick et al., 2017). In addition, DOI, age at injury and level of lesion did not play a
role in AS. Again, this is similar to our previous report (Katzelnick et al., 2017); however, this is
in contrast to a recent study that reported a correlation between stiffness index and duration of
injury (Wu et al., 2016). The disparity between our findings and those previously reported may
be attributed to inclusion of individuals with acute and chronic injuries (3-518 months) in the
prior report and differing methodology (i.e. stiffness index by digital volume pulse vs. PWV).
It has become increasingly clear that individuals with SCI have increased AS compared
to age-matched able-bodied controls (Katzelnick et al., 2017; Phillips et al., 2012; Huang et al.,
2013; Miyatani et al., 2014; Lee et al., 2017; Wecht et al., 2004). Conversely, the relationship
between level of lesion and AS is still not certain. We previously reported that AS (measured by
augmentation index at the radial artery) was increased in HIGH-SCI compared to LOW-SCI
(Katzelnick et al., 2017); however in the present study, we found no difference in PWV between
the SCI groups. This may be attributed to differing methodology. In the present study, PWV was
measured at the carotid and femoral arteries, which is gold standard measurement for AS;
however, in our previous work, the augmentation index was performed at the radial artery, where
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we would expect to have full sympathetic innervation in individuals with low cord lesions, but
would be partially to completely decentralized among those with high cord lesions. Although not
significant, individuals with HIGH-SCI had slightly higher AS than LOW-SCI group. With a
larger sample size, we may see a significant difference between the two groups. Miyatani et al.
(2014) reported higher AS in individuals with paraplegia (T1-T12) compared to individuals with
tetraplegia (C2-C8). This is highly surprising given that most risk factors for increased AS is
increased in those with higher level injuries including BP liability, physical inactivity, and
impaired SNS function (Lee et al., 2017; West et al., 2012; Popa et al., 2010; Weaver et al.,
2012). Additionally, Miyatani and colleagues included all levels of thoracic injuries in their
paraplegia group, including those that have control of their splanchnic bed and those who do not.
It is essential to understand that within the SCI population, there is a large degree of
cardiovascular variability that is directly related to the specific level of injury.
AS is recognized as an independent predictor for CVD (Vlachopoulos et al. 2010), and
because CVD is the leading cause of mortality in the SCI population (Craigg et al.,), AS may
serve as a vital prognostic tool (Currie et al., 2019). An individual presenting with AS of greater
than 10 m/s is considered at elevated risk of a cardiovascular event (Van Bortel et al., 2011), and
in our sample, we have three individuals with HIGH-SCI that have a AS above 10 m/sec.
Furthermore, we compared the AS values in our study with available general population
reference values (Boutouyrie and Vermeersch, 2010). As a result, highly abnormal AS was
present in 63% of the HIGH-SCI group and 45% of the LOW-SCI group. There was no
abnormal AS in the age-matched control group. Of note, the clinical threshold for abnormal AS
values have not been established in the SCI population. These results demonstrate that
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individuals with high-level SCI may have higher related cardiovascular-related risk compared to
individuals with low-level SCI.
Orthostatic Blood Pressure and Renin Levels
Our first aim was to investigate the influence of the change in BP and change in plasma
renin from supine rest to 60-degree HUT. Plasma renin activity has been reported to be elevated
in response to HUT in persons with high-level injuries (Mathias et al., 29175; Mathias et al.,
1980) in order for this population to regulate BP during an orthostatic provocation. All renin
values were within normal range (supine: 3-30pg/ml; seated/standing: 7-50 pg/ml) (Bauman et
al., 2017), except for two individuals in the LOW-SCI group. Both of them had higher supine
plasma renin levels (Subject 1: 40.31 pg/ml and Subject 2: 78.78 pg/ml) and subject 2 had higher
than normal plasma renin level during 60-degree HUT (62.76 pg/ml). This may be due to an
analysis error.
The change in plasma renin levels were inversely related to the change in BP from supine
to HUT at 60-degrees in the total sample. We hypothesized that we would see a positive
relationship; however, this inverse relationship suggests that those with greatest plasma renin
response to HUT, also have the greatest fall in BP. We might have seen an increase in SBP if we
measured the blood pressure the last 5 minutes of the HUT, instead of the first 5 minutes in order
to see the increased renin levels vasoconstricting the arteries and increasing BP. Handrakis and
his colleagues (2009) demonstrated that there was a correlation between change in plasma renin
and an increase in MAP in individuals with tetraplegia, which suggests that those who have
increased RAAS activity, had an increase in BP.
Plasma Renin and Arterial Stiffness
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Our second aim was to determine if increased reliance on the RAAS for orthostatic BP
regulation contributes to differences in AS. Overstimulation of RAAS triggers numerous
signaling pathways that are implicated in vascular remodeling, endothelial dysfunction, and other
mechanisms that may contribute to AS and accelerated vascular aging (Neves et al., 2018). The
RAAS system acts predominately on restricting arterioles and, has been shown to modify the
structure and function by altering collagen and elastin fibers (Mahmud and Freely, 2004; Duprez,
2006; Neves et al., 2018). Although many studies have hypothesized that increases in RAAS
may be related to increases in AS in the SCI population (Katzelnick et al., 2017; West et al.,
2013; Wecht and Bauman, 2018), this report is the first to document the change in plasma renin
during HUT is directly associated with AS in the HIGH-SCI group. The chronic contraction of
blood vessels and other vascular remodeling processes of RAAS during orthostatic challenges is
a significant contributor to increased AS.
Individuals with asymptomatic hypotension are often undiagnosed and untreated because
it is believed that hypotension may actually have cardiovascular benefit. However, evidence has
shown adverse impact of asymptomatic OH on activities of daily living (Currie et al., 2015;
Barber et al., 2000), quality of life (Carlozzi et al., 2013; Craig et al., 2016; Jegede et al., 2010),
cognitive function (Jegede et al., 2010; Phillips et a l., 2014) and cerebral circulation (Wech et
al., 2013; Wecht et al., 2012; Phillips et al., 2017) in persons with chronic SCI, and this should
raise clinical concern. Our findings lend further support that it is necessary to normalize and
stabilize BP, even in asymptomatic individuals with SCI, to reduce the dependency on RAAS
and improve cardiovascular health and longevity.
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Chapter V

SUMMARY AND CONCLUSIONS

Conclusion
The SCI population has an increased prevalence of OH due to impairment in supraspinal
regulation affecting the autonomic cardiovascular control. Adverse impact of asymptomatic OH
during activities of daily living, such as transfers and rehabilitation, has not been fully
appreciated, but should raise clinical concern. Our findings lend further support that the SCI
population is prone to premature onset of CVD compared to age-matched uninjured able-bodies.
A new risk factor contributing to increased AS in the SCI population may be the hyperactivity of
RAAS in order to maintain BP and avoid syncope. Further research should examine
pharmalogical and nonpharmalogical techniques to increase BP and suppress activation of
RAAS in order to decrease CVD in the SCI population.
Limitations
We acknowledge that the small sample size may limit the generalizability of our findings;
however, critical factors that affect AS were controlled for in our study, such as age, height,
weight, and smoking status. Additionally, the sample included a large age range, and we know
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that AS increases with natural aging. Although we matched our SCI population to the uninjured
controls, future studies should have a smaller age range to make sure age is not contributing to
AS. Lastly, we did not survey the SCI sample for autonomic dysreflexia, which is a condition
that increases BP to possibly extreme levels. Autonomic dysreflexia may play a role in AS since
AS is affected by BP.
Future Research
Future research should examine pharmacological (i.e., hypertensive medication) and
nonpharmacological (i.e., transcutaneous stimulation) techniques to increase blood pressure and
suppress activation of RAAS in order to decrease cardiovascular disease in the SCI population.
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